131 related articles for article (PubMed ID: 25478777)
21. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
[TBL] [Abstract][Full Text] [Related]
22. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
[TBL] [Abstract][Full Text] [Related]
23. Bridging and downstaging to transplantation in hepatocellular carcinoma.
Ettorre GM; Levi Sandri GB; Santoro R; Lepiane P; Colasanti M; Vennarecci G
Future Oncol; 2014 Nov; 10(15 Suppl):61-3. PubMed ID: 25478770
[No Abstract] [Full Text] [Related]
24. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study.
Wieners G; Mohnike K; Peters N; Bischoff J; Kleine-Tebbe A; Seidensticker R; Seidensticker M; Gademann G; Wust P; Pech M; Ricke J
Radiother Oncol; 2011 Aug; 100(2):314-9. PubMed ID: 21497930
[TBL] [Abstract][Full Text] [Related]
25. [Radiotherapy for metastatic breast cancer].
Imajo Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():484-90. PubMed ID: 17682198
[No Abstract] [Full Text] [Related]
26. Selective internal radiation therapy: validation of intraoperative dosimetry.
Burton MA; Gray BN; Kelleher DK; Klemp PF
Radiology; 1990 Apr; 175(1):253-5. PubMed ID: 2315490
[TBL] [Abstract][Full Text] [Related]
27. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
28. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
[TBL] [Abstract][Full Text] [Related]
29. Latest selective internal radiation therapy recommendations from EU proctors.
Maleux G
Future Oncol; 2014 Nov; 10(15 Suppl):69-72. PubMed ID: 25478772
[No Abstract] [Full Text] [Related]
30. Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?
Hoffmann RT; Jakobs TF; Kubisch CH; Stemmler HJ; Trumm C; Tatsch K; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Apr; 74(1):199-205. PubMed ID: 19269763
[TBL] [Abstract][Full Text] [Related]
31. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
32. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
Uthappa MC; Ravikumar R; Gupta A
Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
[TBL] [Abstract][Full Text] [Related]
33. CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.
Collettini F; Poellinger A; Schnapauff D; Denecke T; Wust P; Braicu IE; Sehouli J; Hamm B; Gebauer B
Anticancer Res; 2011 Aug; 31(8):2597-602. PubMed ID: 21778310
[TBL] [Abstract][Full Text] [Related]
34. Oesophageal ulceration after selective internal radiation therapy in a patient with carcinoma of unknown primary.
Kubisch CH; Beigel F; Ihrler S; Goke B; Reiser MF; Hoffmann RT
Z Gastroenterol; 2010 May; 48(5):546-50. PubMed ID: 20449787
[TBL] [Abstract][Full Text] [Related]
35. [Chemoperfusion and embolization in the treatment of liver metastases].
Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
[TBL] [Abstract][Full Text] [Related]
36. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
[TBL] [Abstract][Full Text] [Related]
37. Liver metastases from neuroendocrine tumors.
Kennedy A
Future Oncol; 2014 Nov; 10(15 Suppl):83-7. PubMed ID: 25478775
[No Abstract] [Full Text] [Related]
38. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
[TBL] [Abstract][Full Text] [Related]
39. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
[TBL] [Abstract][Full Text] [Related]
40. Radioembolization of liver tumors with yttrium-90 microspheres.
Ahmadzadehfar H; Biersack HJ; Ezziddin S
Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
